Fintel reports that on January 30, 2025, Stifel upgraded their outlook for Edwards Lifesciences (NYSE:EW) from Hold to Buy.

Edwards Lifesciences Corporation (NYSE:EW) shares are trading higher on Thursday. Stifel analyst Rick Wise upgraded Edwards from Hold to Buy, raising the price forecast to $90 from $75. Wise suggests ...

In the latest quarter, 11 analysts provided ratings for Edwards Lifesciences EW, showcasing a mix of bullish and bearish ...

Edwards Lifesciences (NYSE: EW) stock rises after Stifel upgrades to Buy, citing potential for TAVR growth acceleration in 2025. Read more here.

Shares of Edwards Lifesciences Corp. EW advanced 2.94% to $73.22 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.53% to ...

Edwards Lifesciences Corp (EW) stock saw a decline, ending the day at $71.13 which represents a decrease of $-1.43 or -1.97% from the prior close of $72.56. The stock opened at $72.5 and touched a low ...

New 20-year data show a survival rate of 90% with few repeat surgeries after this complex operation that can only be ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Alibaba Group Holding Ltd. (BABA), ...

MedTekon 2025, the flagship event of the Medical Technology Association of India (MTaI), convened policymakers, global ...

SMS Lifesciences India Ltd., incorporated in the year 2006, is a Small Cap company (having a market cap of Rs 380.99 Crore) operating in Pharmaceuticals sector. SMS Lifesciences India Ltd. key ...